Interpretation of Folate Results in Hemolytic Plasma Samples: A Practical Approach
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Folate analysis in plasma is affected by hemolysis, which can lead to biased results. However, the degree of hemolysis that is considered acceptable is unclear. We explored the relationship between folate concentration and degree of hemolysis. Heparin plasma samples (N=77, hemolysis index ≤10 μmol/L) were spiked with increasing amounts of corresponding patient-specific hemolysate. Subsequently, the folate concentration and hemolysis index were measured using two Roche Cobas platforms, and their incremental relationship was investigated. The folate concentration ranged from 2.9 to 30.9 nmol/L with a median (interquartile range) of 11.4 (8.6–19.1) nmol/L. The linear relationship between the increments in folate concentration and hemolysis index was approximated by the function y=1.86x+1.56 (R2=0.996), where x represents the laboratory-specific critical difference in folate concentration, which can be calculated from the analytical variation of the employed folate assay(s), and y represents the hemolysis threshold. The hemolysis threshold did not significantly differ between the tertiles of plasma folate concentration (P=0.10). In conclusion, we have provided an evidence-based approach that can be used to reliably interpret folate concentrations in hemolytic samples, independent of the patient’s folate status.
Abstract
Folate analysis in plasma is affected by hemolysis, which can lead to biased results. However, the degree of hemolysis that is considered acceptable is unclear. We explored the relationship between folate concentration and degree of hemolysis. Heparin plasma samples (N=77, hemolysis index ≤10 μmol/L) were spiked with increasing amounts of corresponding patient-specific hemolysate. Subsequently, the folate concentration and hemolysis index were measured using two Roche Cobas platforms, and their incremental relationship was investigated. The folate concentration ranged from 2.9 to 30.9 nmol/L with a median (interquartile range) of 11.4 (8.6–19.1) nmol/L. The linear relationship between the increments in folate concentration and hemolysis index was approximated by the function y=1.86x+1.56 (R2=0.996), where x represents the laboratory-specific critical difference in folate concentration, which can be calculated from the analytical variation of the employed folate assay(s), and y represents the hemolysis threshold. The hemolysis threshold did not significantly differ between the tertiles of plasma folate concentration (P=0.10). In conclusion, we have provided an evidence-based approach that can be used to reliably interpret folate concentrations in hemolytic samples, independent of the patient’s folate status.
참고문헌 (17)
- Bailey LB, "Biomarkers of nutrition for development-folate review", J Nutr, 145, pp.1636S~1680S (2015)
- Sobczyńska-Malefora A, "Laboratory assessment of folate (vitamin B9) status", J Clin Pathol, 71, pp.949~956 (2018)
- Farrell CJ, "Red cell or serum folate: what to do in clinical practice?", Clin Chem Lab Med, 51, pp.555~569 (2013)
- Thelen MHM, "Expressing analytical performance from multisample evaluation in laboratory EQA", Clin Chem Lab Med, 55, pp.1509~1516 (2017)
- "Serum and red blood cell folate concentrations for assessing folate status in populations"[URL]
- CLSI, "Interference testing in clinical chemistry: approved Guideline" (2005), Clinical and Laboratory Standards Institute
- turbidity indices as indicators of interference in Clinical Laboratory Analysis; approved guideline, "Hemolysis, icterus, and lipemia", pp.2012, CLSI
- Grzych G, "Benefit of point of care testing in patient with major hyperleukocytosis", Clin Biochem, 65, pp.55~57 (2019)
- Swendseid ME, "The concentration of folic acid in leukocytes; observations on normal subjects and persons with leukemia", Cancer Res, 11, pp.864~867 (1951)
- Rana OB, "Folic acid activity in leukemia and cancer", Cancer Res, 25, pp.221~224 (1965)
- Monneret D, "Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods", Scand J Clin Lab Invest, 75, pp.162~169 (2015)
- Coskun A, "How can we evaluate differences between serial measurements on the same sample? A new approach based on within-subject biological variation", Clin Chem Lab Med, 55, pp.e44~e46 (2017)
- Borel MJ, "Day-to-day variation in iron-status indices in healthy men and women", Am J Clin Nutr, 54, pp.729~735 (1991)
- Pineda-Tenor D, "Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population", Clin Chem Lab Med, 51, pp.851~862 (2013)
- Lacher DA, "Biological variation of laboratory analytes based on the 1999-2002 National Health and Nutrition Examination Survey", Natl Health Stat Report, 21, pp.1~7 (2010)
- Pfeiffer CM, "Enzymatic deconjugation of erythrocyte polyglutamyl folates during preparation for folate assay: investigation with reversed-phase liquid chromatography", Clin Chem, 42, pp.1847~1854 (1996)
- Galloway M, "Red cell or serum folate? Results from the National Pathology Alliance benchmarking review", J Clin Pathol, 56, pp.924~926 (2003)